Searche

Your search for "editing" matched 860 page(s).

Showing results 741 to 750.

Diversity in clinical trials: It takes a village - Volume 32, Issue

Clinical trials are becoming more complex and the efforts to optimise drug development are rapidly evolving. This Q&A gives a short overview of the strategies Bristol Myers Squibb implements to incorporate diversity into the clinical trial…

From the Editor - Volume 32, Issue

Biotechnology – diverse as the colours of the rainbow Ask 10 people what “biotechnology” means and you will get 10 different answers. In this column, the Editor-in-Chief highlights the variety and breadth of the field and notes the important role…

Translating medical reports: Challenges and quality assurance - Volume 33, Issue

This article discusses the challenges and quality assurance measures implemented by the authors when translating medical reports. In particular, the authors discuss the challenges posed by acronyms, handwritten and scanned text, and desktop…

Speaking your patients’ language – Is it really worth it? The impact of translation on multilingual patient education materials - Volume 33, Issue

This article discusses the role of translation and its impact on the success of patient education materials, particularly in the context of patient recruitment and retention for clinical trials. We examine how translation and localisation help…

President’s Message - Volume 33, Issue

See you in Valencia… Time is flying. We just left the autumn conference and now are approaching our main EMWA event – the spring conference, to take place May 7– 11, 2024. This time we go to Valencia, and I am sure that no one needs to be…

Outgoing President's Message - Volume 33, Issue

Time flies – nothing new in that then! The year of my presidency is finished, so it is time to look back and summarise. It was my first task as a president to introduce a 5-year strategic plan for 2023–2027, and together with the whole Executive…

Connecting through screens: Navigating relationships with patients and advocacy groups in a digital world - Volume 33, Issue

As a Healthcare Publications Editor at Karger Publishers, I write, edit, and oversee the development of patient information resources in our Fast Facts for Patients series. Soft skills are vital in my role at Karger, where we are committed to…

Anonymisation reports from 2016 to 2017: A preliminary analysis - Volume 27, Issue

The anonymisation report (AR) is a new and relatively unknown regulatory document, submitted as part of the redacted package of a marketing authorisation application under the EMA Policy 0070. The report documents the methodology of…

Vaccines and immunotherapies - Volume 27, Issue

The use of vaccines and immunotherapies in medicine dates back to the end of the 18th century and the work of Edward Jenner, the father of immunology. Jenner, building on the observations of John Fewster in 1768, showed that inoculation with the…

News from the EMA - Volume 27, Issue

April 12, 2018 – The European Medicines Agency's (EMA) and its European and international partners have successfully strengthened their interactions to improve the oversight of active pharmaceutical ingredient (API) manufacturers worldwide, as…

Visit the EMWA website

Search

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Scope

Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.

Medical Writing is listed in the following indexes: